– SOUTH SAN FRANCISCO, Calif., Aug. 23, 2023 /PRNewswire/ — Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, has secured $255 million in Series C funding led by new investor Koch Disruptive Technologies. In connection with the financing, David Mauney, Managing…Read More
Cellares Raises 255M Series C to Launch First Integrated Development and Manufacturing Organization IDMO and Pioneering Smart Factory to Meet Global Demand for LifeSaving Cell Therapies
